Results 61 to 70 of about 71,226 (307)
A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening [PDF]
, 2018 BACKGROUND:Cardiac computed tomography (CT) is often performed in patients who are at high risk for lung cancer in whom screening is currently recommended.
Bandiera, A +10 more
core +1 more source
In-Stent Ulceration: An Unusual Pathology
Case Reports in Cardiology, 2014 In-stent restenosis occurs in 10–60% of cases undergoing interventional therapy. Many mechanisms explain the reason for in-stent restenosis, but restenosis due to an ulcerated plaque is very rare and has not been well reported in the literature.
Jagadeesh Kumar Kalavakunta +2 more
doaj +1 more source
Inverse uncertainty quantification of a mechanical model of arterial tissue with surrogate modeling [PDF]
arXiv, 2022 Disorders of coronary arteries lead to severe health problems such as atherosclerosis, angina, heart attack and even death. Considering the clinical significance of coronary arteries, an efficient computational model is a vital step towards tissue engineering, enhancing the research of coronary diseases and developing medical treatment and ...
arxiv
Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis - Tissue characteristics compared to primary atherosclerosis [PDF]
, 2004 Pathogenic events leading to in-stent restenosis (ISR) are still incompletely understood. Among others, inflammation, immune reactions, deregulated cell death and growth have been suggested. Therefore, atherectomy probes from 21 patients with symptomatic
Abdelmegui AE +24 more
core +1 more source
Кардиоваскулярная терапия и профилактика, 2016 Aim. To study the significance of clinical parameters and cardiovascular risk factors (CVR) for restenosis development at long terms after percutaneous coronary intervention (PCI) as a possible displaying of neoatherosclerosis development (NA).Material ...
V. P. Mazaev +2 more
doaj +1 more source
Finite element modelling of in-stent restenosis [PDF]
arXiv, 2020 From the perspective of coronary heart disease, the development of stents has come significantly far in reducing the associated mortality rate, drug-eluting stents being the epitome of innovative and effective solutions. Within this work, the intricate process of in-stent restenosis is modelled considering one of the significant growth factors and its ...
arxiv
A Synopsis of Stent Graft Technology Development [PDF]
arXiv, 2023 Coronary artery disease (CAD) is a leading cause of death worldwide. Treatments have evolved, with stenting becoming the primary approach over bypass surgery. This article reviews the evolution of coronary stent technology, starting from the first angioplasty in 1977. Pioneers like Forssmann, Dotter, and Gruentzig established the foundation.
arxiv
Materials Advances in Devices for Heart Disease Interventions
Advanced Materials, EarlyView.This review examines the crucial role of materials in heart disease interventions, focusing on strategies for monitoring, managing, and repairing heart conditions. It discusses the material requirements for medical devices, highlighting recent innovations and their impact on cardiovascular health.
Gagan K. Jalandhra +11 more
wiley +1 more source
BMC Cardiovascular Disorders, 2019 Background In-stent restenosis remains an unresolved issue. Inflammation plays a pivotal role in the process of in-stent restenosis. Significant and positive associations were found between red blood cell distribution width (RDW) and inflammation.
Ning Geng +5 more
doaj +1 more source
Role of noncoding RNA in vascular remodelling [PDF]
, 2016 Purpose of review: Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are becoming fundamentally important in the pathophysiology relating to injury-induced vascular remodelling.
Baker, Andrew H. +2 more
core +1 more source